Clearly KC Podcast

Clearly KC host Dr. Melissa Barnett welcomes the Chief Medical Officer at Epion Therapeutics Dr. Michael Belin, and VP Clinical Operations at Epion Therapeutics Tiffany Haynes to discuss advances in keratoconus diagnosis and treatment. Dr. Bellin highlights the importance of early detection and intervention, made possible by modern imaging tools like corneal tomography. The conversation also covers Epion’s Phase 3 clinical trial of EpiSmart, a new epithelium-on crosslinking intended to preserve the cornea’s surface, reduce discomfort, speed up recovery time, and minimize the risk of scar formation and infection. Tiffany explains how patients can join the clinical trial, currently enrolling at 26 sites in the United States.